Editor's Special Episode: Future Directions in MPN Treatment with Dr. Hobbs
The HemOnc Pulse
00:00
Rusfertide safety profile in VERIFY
Dr. Hobbs reviews VERIFY safety, noting injection‑site reactions and no concerning signal for secondary cancers versus placebo.
Play episode from 12:23
Transcript
